Peregrine Capital Management LLC Reduces Stock Holdings in Guardian Pharmacy Services, Inc. $GRDN

Peregrine Capital Management LLC reduced its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 8.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 201,603 shares of the company’s stock after selling 19,453 shares during the period. Peregrine Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $7,592,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Valiant Capital Management L.P. boosted its holdings in Guardian Pharmacy Services by 15.8% in the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock worth $37,085,000 after acquiring an additional 167,741 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Guardian Pharmacy Services by 3.3% during the third quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock valued at $30,000,000 after acquiring an additional 36,072 shares in the last quarter. Franklin Resources Inc. raised its position in shares of Guardian Pharmacy Services by 8.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock valued at $27,705,000 after purchasing an additional 80,033 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Guardian Pharmacy Services by 9.1% in the 3rd quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock valued at $27,675,000 after purchasing an additional 88,296 shares during the last quarter. Finally, Boston Partners boosted its stake in Guardian Pharmacy Services by 0.7% in the 4th quarter. Boston Partners now owns 1,054,636 shares of the company’s stock worth $31,995,000 after purchasing an additional 7,759 shares in the last quarter.

Guardian Pharmacy Services Stock Up 0.9%

Guardian Pharmacy Services stock opened at $42.23 on Thursday. The stock has a 50-day moving average price of $39.02 and a 200 day moving average price of $35.22. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of 50.87, a price-to-earnings-growth ratio of 2.75 and a beta of 0.05. Guardian Pharmacy Services, Inc. has a 52 week low of $19.30 and a 52 week high of $44.00.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.05. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The company had revenue of $336.60 million for the quarter, compared to the consensus estimate of $329.89 million. During the same quarter in the prior year, the company earned $0.22 EPS. Guardian Pharmacy Services’s quarterly revenue was up 2.2% on a year-over-year basis. Research analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Analyst Ratings Changes

GRDN has been the topic of several research analyst reports. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Raymond James Financial reaffirmed an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Weiss Ratings downgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 11th. UBS Group reissued a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Finally, Wall Street Zen downgraded Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, May 9th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $42.83.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.